Want to see IN:VIYASH full AI Analyst Report?
VIYASH Stock Chart & Stats
₹210.65
-₹3.94(-2.00%)
At close: 4:00 PM EST
₹210.65
-₹3.94(-2.00%)
Day’s Range― - ―
52-Week Range₹167.45 - ₹297.90
Previous CloseN/A
VolumeN/A
Average Volume (3M)119.95K
Market Cap
₹110.01B
Enterprise Value₹85.83K
Total Cash (Recent Filing)₹2.70B
Total Debt (Recent Filing)₹4.90B
Price to Earnings (P/E)77.5
Beta1.24
Next Earnings
Aug 11, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.25
Shares Outstanding436,875,500
10 Day Avg. Volume209,903
30 Day Avg. Volume119,946
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)2.72
Price to Sales (P/S)2.32
P/FCF Ratio61.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)9.3
Revenue Forecast (FY)₹38.99B
Bulls Say, Bears Say
Bulls Say
Revenue & Margin ReboundA durable, large-scale revenue rebound combined with materially higher EBIT/EBITDA margins signals stronger product demand and improved operating leverage. If sustained, this scale enables better fixed-cost absorption, supports reinvestment, and meaningfully improves mid-term profitability versus prior loss years.
Stronger Balance SheetSignificantly reduced leverage (D/E ~0.17) materially lowers refinancing and solvency risk and increases financial flexibility. This structural improvement supports funding for R&D, regulatory work or selective M&A, and improves resilience to macro shocks over the coming months.
Improving Cash GenerationFree cash flow moving to solid positive territory and rising year over year shows improved cash-generation capacity. Durable FCF supports organic investment, reduces reliance on external financing, and helps sustain operations and growth initiatives over the medium term.
Bears Say
Historic Earnings VolatilityMulti-year volatility including loss periods indicates the company has not yet built a reliably stable earnings base. Structural demand variability or execution gaps raise the risk that recent improvements could revert, making sustained profitability uncertain over the next several months.
Weak Cash ConversionDespite positive FCF, operating cash flow remains a low single-digit share of revenue and FCF is under ~50% of net income. Persistent weak cash conversion increases sensitivity to working-capital swings and constrains free cash available for strategic uses, limiting durability of reported profits.
Margin Sustainability RiskMargins have improved but remain cyclical, with prior negative EBIT and low net margin in recent years. This suggests earnings quality is not fully proven and that margin gains may be sensitive to pricing, cost structure or one-off items, posing medium-term sustainability risk.
Viyash Scientific News
VIYASH FAQ
What was Viyash Scientific Limited’s price range in the past 12 months?
Viyash Scientific Limited lowest stock price was ₹167.45 and its highest was ₹297.90 in the past 12 months.
What is Viyash Scientific Limited’s market cap?
Viyash Scientific Limited’s market cap is ₹110.01B.
When is Viyash Scientific Limited’s upcoming earnings report date?
Viyash Scientific Limited’s upcoming earnings report date is Aug 11, 2026 which is tomorrow.
How were Viyash Scientific Limited’s earnings last quarter?
Viyash Scientific Limited released its earnings results on May 19, 2026. The company reported ₹1.17 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Viyash Scientific Limited overvalued?
According to Wall Street analysts Viyash Scientific Limited’s price is currently Overvalued.
Does Viyash Scientific Limited pay dividends?
Viyash Scientific Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Viyash Scientific Limited dividends here
What is Viyash Scientific Limited’s EPS estimate?
Viyash Scientific Limited’s EPS estimate is 2.
How many shares outstanding does Viyash Scientific Limited have?
Viyash Scientific Limited has 436,875,500 shares outstanding.
What happened to Viyash Scientific Limited’s price movement after its last earnings report?
Viyash Scientific Limited reported an EPS of ₹1.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.373%.
Which hedge fund is a major shareholder of Viyash Scientific Limited?
Currently, no hedge funds are holding shares in IN:VIYASH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Viyash Scientific Limited
Viyash Scientific Limited is a global veterinary healthcare company with operations spanning Europe, Asia, and other international markets. It specializes in developing and supplying finished dosage forms for a range of therapeutic applications, including nutritional support, pain relief, parasite control, antibiotic treatments, and gut health solutions. These products cater to various animals like livestock, poultry, and domestic pets. Additionally, the company extends its expertise through analytical testing and specialized veterinary formulation services. Originally established as Sequent Scientific Limited, the company officially adopted the name Viyash Scientific Limited in January 2026. Founded in 1985, its corporate headquarters are situated in Hyderabad, India. Currently, Viyash Scientific Limited functions as a subsidiary of CA Harbor Investments.
Technical Analysis
Akums Drugs and Pharmaceuticals Limited
―
Alembic Pharmaceuticals Limited
―
Caplin Point Laboratories Limited
―
Glenmark Life Sciences Limited
―
Strides Pharma Science Ltd
―